Yesterday in this space I argued that Donald Trump should shut up. Amtrak’s recent decision to stock Victory Brewing Company’s Hop Devil IPA on some trains showed that America is already great again.
Today the evidence from the nation’s northeastern rail corridor is mixed. On the one hand,we have the livestock-pen-indignity of the Penn Station waiting area, in which people mill around waiting for the last-second announcement of which gate to rush toward. (Yes! I know about the secret lower-level workaround. I’m thinking of my fellow citizens.) This is better than most commercial airports, but just barely. Penn Station veterans will know that the miracle of the shot below is that you can see a little area of unoccupied linoleum. But after all, this was 3 pm.
If Trump would boil his platform down to, Making Penn Station Great Again, I might sign on.
On the other hand, I give you now the Zaro Family Bakery, a Penn Station vendor doing its part to make things great all around. In its cooler we find … cans of wonder! Sierra Nevada Torpedo, in the darker-green cans, plus its mainstay Pale Ale; Sam Adams Rebel IPA and (lower down) its mainstay Boston Lager; plus Brooklyn Lager and Magic Hat Not Quite Pale Ale, all at $5 per 16-ounce can. More than in a liquor store, less than on the train.
As always our world is complex. But I have a can of Torpedo with me, and the wifi is working on the train as it rolls along through the clear and icy landscape, so for now I’ll return to the can-is-half-full perspective on our land.
A new entry on Amtrak’s cafe-car offerings: Victory Brewing Company’s Hop Devil IPA!
This is a step forward on an already progressive menu. For years Amtrak has offered Sam Adams Boston Lager on northeastern routes, plus Yuengling — and then Dogfish Head’s super-potent 90 Minute IPA, which at 9% alcohol is too much for me. [Update: and I hear from a reader that San Diego’s wonderful Stone beers have been available on the west coast Surfliner.]
When my wife and I lived in Austin long ago, while she was a UT graduate student and I was working for the then-new Texas Monthly (and then-State Senator, now Congressman, Lloyd Doggett), we spent what seemed like every evening with friends at the famous Scholz Garten open-air beer garden downtown. The range of regional beer choice in those days was Shiner, Pearl, or Lone Star from Texas, and Negro Modelo, Bohemia, Dos Equis, etc from further south.
The craft brew age has come to Texas as it has everywhere else. Continuing our saga of appreciation for the increasing range of American beer greatness, please consider the four offerings above. They are shown on a Dallas doorstep, protectively nestled on a blanket with Dress Mackenzie tartan. From left to right:
Deep Ellum IPA, again from Deep Ellum brewery. If forced to choose between this and Mosaic, I would choose both.
My main point with these updates is to add little chronicles of the ongoing golden age of beer. For academic substantiation on that point, check out the new Journal of Wine Economics for a history and analysis of the American craft brewing movement by three academic economists: Kenneth Elzinga, Carol Horton Tremblay, and Victor Tremblay. A PDF of their 33-page essay is here. (Thanks to Russ Mitchell for spotting it.) The report includes this map of craft brewing’s expansion, after Jimmy Carter took the historic step of legalizing home brewing in 1979.
I have exactly two sources of recent interest in the fascinating-to-millions-of-people-but-previously-not-to-me world of SEC football.
One is the delightful recent book by Stuart Stevens — former Mitt Romney campaign strategist, book and TV writer, author for The Atlantic and other publications — called The Last Season. It’s the story of how, after the painful loss with Romney, Stevens spent a late summer and fall going with his 95-year-old father to every game of the football season for the University of Mississippi, his father’s alma mater. The book is about the modern role of football, especially the SEC variety. But it is also about the pre- and post- Civil Rights era deep south, about fathers and sons, about self-knowledge and self-delusion, about life’s losses and gains. I recommend it. It was 99% because of the book that I watched part of the game this afternoon in which Ole Miss steamrolled LSU.
The other is our series of visits in the past 18 months to the Golden Triangle of Mississippi, one of whose three component cities is Starkville, home of Mississippi State. One week ago I was flying over the Mississippi State campus with members of the Atlantic’s video crew, getting as close to the Alabama-Mississippi State showdown in Wade Davis Stadium as the gametime no-fly zone would allow.
A year ago at this time, the Mississippi State Bulldogs were just ending a multi-week run as the undefeated No. 1 team in the country. (They ended up with three losses, and a final ranking as #11.) In their game last weekend, the Bulldogs were crushed by the Crimson Tide. But as I type the Bulldogs are in an extremely high-scoring cliffhanger against the Arkansas Razorbacks. I will intentionally post this before I know the outcome.
Until three years ago, Mississippi had nothing like a craft brew industry. State law limited the alcohol content of beer to 5%, and most craft beers are above that. Since the law was changed in 2012, new breweries have sprung up. A week ago, at the indispensable Mississippi beer center known as the SmokeStack (in West Point), I loaded up on the Magnolia State products you see at top.
Very different styles, but I liked them all (and liked the two from Lazy Magnolia best). Keep an eye out for them; enjoy Stuart Stevens’s book; and now I’ll check to see how the Dogs-Hogs game turned out.
Update Very dramatic! The Dogs won in the final minute, 51-50, by blocking a Hogs chip-shot short-yardage field goal attempt with 40 seconds to go. I think I will now leave SEC football to its actual fans, going out on top after this exciting evening game.
Have been off the grid, mainly in Mississippi, so here is a good-news way to ease back in.
1) Ballast Point Bonanza. I’ve long enjoyed Ballast Point beers, from San Diego. Earlier this month I mentioned its lightish Longfin Lager. My favorites from its lineup are actually its Sculpin IPA, as shown at right, and the packs-a-punch, spicy-plus-bitter Habanero Sculpin. Also great: Ballast Point’s Fathom IPL (India Pale Lager), Big Eye IPA, and Dorado Double IPA.
In addition to liking the beer, I’ve liked the idea that Ballast Point was co-founded by fellow Cirrus airplane pilot (and skilled flight instructor) Bill Graham, whom I’ve come to know at a number of aviation gatherings over the years. When I saw him at a Cirrus convention in Dallas a few weeks ago, he didn’t mention that he was about to sell the craft brewery for … one billion dollars. That’s the news — sale of Ballast Point to Constellation Brands as a California-based non-tech billion-dollar “unicorn” — that was announced yesterday. Congratulations to the company, and to the Graham family.
Only little cloud on the horizon: some of Constellation’s other beer brands include Corona, Pacifico, and Tsingtao. Hmmm. Please keep your brewmasters, Bill!
2) Beer Road Trip. From Nathan Yau at FlowingData, a wonderful algorithmically generated map of how to visit the greatest number of the nation’s best craft breweries with the most efficient route. Not all of them are there — no Bent Paddle or Fitger’s of Duluth, Minnesota, no Yazoo of Nashville, no Victory Brewing (and its famous Hop Devil) of Downingtown, Pennsylvania, no DC Brau of DC, no Terrapin of Athens, Georgia, none of the Mississippi breweries I’ll be writing about shortly, of course no Hangar 24 or Escape or Ritual of Redlands, California — but, to be fair, it covers a lot. Nice job.
3) Know Your Craft Beers. The LA Times story on the Ballast Point sale also has a interesting / challenging test on “craft” vs. “crafty” beers — ones that are still independent, versus brands that are part (as Ballast Point is about to be) of larger chains. Many of the “crafty” beers are still very good! But see if you do better on this test than I did…
This was a day of travel-related travails of many sorts. Had expected to be en route to Mississippi on an American Futures-related update trip. Instead (seemingly) unrelated but mounting mechanical and electrical problems in a small plane meant no-go tonight.
The silver lining was the excuse to try out a place I had heard about (and whose beer I’d bought) but not visited: one of Dogfish Head’s three DC-area outlets. The brewery and headquarters are nearby in Delaware. I say: even if you’re not reflecting on a cancelled trip, worth checking out.
Posters for their beers:
Since you asked, the tattoo on the right says 酒 , jiu, for liquor or spirits. As in 啤酒, pijiu, for beer or 葡萄酒, putaojiu, for wine. Pijiu was the specialty at Dogfish head.
It’s been a while since I’ve been on the beer beat, and the tips I’d like to pass along are mounting up. So henceforth a new feature: early each month, an homage to interesting beers.
On this warmish November 1 in Washington DC (hmm, I wonder why that could be), I show you four canned beers that we had laid in before watching the GOP/CNBC debate this past week. With a view over the still-fully-leafed trees and bamboo in the backyard, you see these beers lined up left to right, in West-to-East order of their sites of origin:
Longfin Lager, from the Ballast Point brewery of San Diego. From a great brewery, a very nice light lager for those who like light lagers.
Hopnosh IPA, from the Uinta Brewing Company of Salt Lake City. A wonderfully retro-campy label on a wonderful IPA that is one of my staples (when I can find it).
Missile IPA, from the Champion Brewing Company of Charlottesville, Va. I am always mildly embarrassed by the labels on these cans, the brew-world equivalent of the pulpy covers on the wonderful Hard Case Crime series. But, as with the Hard Case novels, I do like this beer.
Brau Pils, from DC Brau here in the nation’s capital. You can say a lot of bad things about Washington, but one of the (many!) good things is the emergence of DC Brau. I usually buy their “The Corruption” IPA, but this is a nice Pilsner.
For weeks, Americans looked on as other countries grappled with case reports of rare, sometimes fatal blood abnormalities among those who had received the AstraZeneca vaccine against COVID-19. That vaccine has not yet been authorized by the FDA, so restrictions on its use throughout Europe did not get that much attention in the United States. But Americans experienced a rude awakening this week when public-health officials called for a pause on the use of the Johnson & Johnson vaccine, after a few cases of the same, unusual blood-clotting syndrome turned up among the millions of people in the country who have received it.
The world is now engaged in a vaccination program unlike anything we have seen in our lifetimes, and with it, unprecedented scrutiny of ultra-rare but dangerous side effects. An estimated 852 million COVID-19 vaccine doses have been administered across 154 countries, according to data collected by Bloomberg. Last week, the European Medicines Agency, which regulates medicines in the European Union, concluded that the unusual clotting events were indeed a side effect of the AstraZeneca vaccine; by that point, more than 220 cases of dangerous blood abnormalities had been identified. Only half a dozen cases have been documented so far among Americans vaccinated with the Johnson & Johnson vaccine, and a causal link has not yet been established. But the latest news suggests that the scope of this problem might be changing.
Concerns about blood clots with Johnson & Johnson underscore just how lucky Americans are to have the Pfizer and Moderna shots.
A year ago, when the United States decided to go big on vaccines, it bet on nearly every horse, investing in a spectrum of technologies. The safest bets, in a way, repurposed the technology behind existing vaccines, such as protein-based ones for tetanus or hepatitis B. The medium bets were on vaccines made by Johnson & Johnson and AstraZeneca, which use adenovirus vectors, a technology that had been tested before but not deployed on a large scale. The long shots were based on the use of mRNA, the newest and most unproven technology.
The protein-based vaccines have moved too slowly to matter so far. J&J’s and AstraZeneca’s vaccines are effective at preventing COVID-19—but a small number of recipients have developed a rare type of blood clot that appears to be linked to the adenovirus technology and may ultimately limit those shots’ use. Meanwhile, with more than 180 million doses administered in the U.S, the mRNA vaccines have proved astonishingly effective and extremely safe. The unusual blood clots have not appeared with Pfizer’s or Moderna’s mRNA technology. A year later, the risky bet definitely looks like a good one.
In early March 2020, Rick Phillips, 63, and his wife, Sheryl Phillips, quietly cloistered themselves in their Indianapolis home. They swore off markets, movie theaters, the gym, and, hardest of all, visits with their three young grandchildren. This April, three weeks after receiving her second shot of Pfizer’s vaccine, Sheryl broke her social fast and walked into a grocery store for the first time since last spring. Rick has yet to join her. He received his shots on the same days his wife received hers. By official standards, he, too, can count himself as fully vaccinated. But he feels that he cannot act as though he is. “I personally remain scared to death,” he told me.
Rick has rheumatoid arthritis, which once rendered him “barely able to walk across the room,” he said. He now treats the condition with an intensely immunosuppressive drug that strips his body of the ability to churn out disease-fighting antibodies. Rick credits the treatment with changing his life. But it might also keep him from developing lasting defenses against COVID-19.
Just months after leaving office, the former president has all but disappeared.
The president was insistent as he left office: “We’re not going anywhere.” It had been a turbulent end of the presidency—impeachment, appalling pardons, and a lengthy dispute over the outcome of the presidential election—but he knew that he had a devoted following, and he had every intention to remain a force in politics. And not just him: His family was eager to cash in on his electoral success, too. Usually a former president laid low for a while after leaving office. He wasn’t going to do that. He’d remain a political force, and the dominant figure in his party.
But the plan didn’t go well. The president sat at his new home—he had decamped from his longtime home state—guzzling Diet Cokes and calling friends to rage about how unfairly he’d been treated and complain about overzealous prosecutors. “You get tired of listening to it,” one friend confessed.
The CDC has finally said what scientists have been screaming for months: The coronavirus is overwhelmingly spread through the air, not via surfaces.
Last week, the CDC acknowledged what many of us have been saying for almost nine months about cleaning surfaces to prevent transmission by touch of the coronavirus: It’s pure hygiene theater.
“Based on available epidemiological data and studies of environmental transmission factors,” the CDC concluded, “surface transmission is not the main route by which SARS-CoV-2 spreads, and the risk is considered to be low.” In other words: You can put away the bleach, cancel your recurring Amazon subscription for disinfectant wipes, and stop punishing every square inch of classroom floor, restaurant table, and train seat with high-tech antimicrobial blasts. COVID-19 is airborne: It spreads through tiny aerosolized droplets that linger in the air in unventilated spaces. Touching stuff just doesn’t carry much risk, and more people should say so, very loudly.
Elite schools breed entitlement, entrench inequality—and then pretend to be engines of social change.
Photo illustrations by Oliver Munday and Arsh Raziuddin; renderings by Justin Metz
This article was published online on March 11, 2021.
Updated at 7:42 p.m. ET on March 26, 2021.
Dalton is one of the most selective private schools in Manhattan, in part because it knows the answer to an important question: What do hedge-funders want?
They want what no one else has. At Dalton, that means an “archaeologist in residence,” a teaching kitchen, a rooftop greenhouse, and a theater proscenium lovingly restored after it was “destroyed by a previous renovation.”
In 1974, John Patterson was abducted by the People’s Liberation Army of Mexico—a group no one had heard of before. The kidnappers wanted $500,000, and insisted that Patterson’s wife deliver the ransom.
Illustrations by Leonardo Santamaria
This article was published online on April 15, 2021.
The Motel El Encanto in Hermosillo, Mexico, served a lavish breakfast that John and Andra Patterson liked to eat on the tiled deck near their suite. The couple would discuss the day ahead over fresh pineapple and pan dulces while their 4-year-old daughter, Julia, watched the gray cat that skulked about the motel’s Spanish arches.
On the morning of March 22, 1974, the Pattersons’ breakfast chatter centered on their search for a permanent home. They were nearing their two-month anniversary of living in Hermosillo, where John was a junior diplomat at the American consulate, and the motel was feeling cramped.
After breakfast, Andra dropped John off at work. Because this was his first posting as a member of the United States Foreign Service, the 31-year-old Patterson had been given an unglamorous job: He was a vice consul responsible for promoting trade between the U.S. and Mexico, which on this particular Friday meant driving out to meet with a group of ranchers who hoped to improve their yield of beef.
That idea, crude though it may be, has something to it. The demographic pattern that’s emerged is striking, and many of the experts I talked with this week told me they suspect that, if the vaccine is ultimately linked to these clots, the relationship will come with a clear-cut sex or gender difference too. (These questions are also being debated with regard to the AstraZeneca vaccine, which contains comparable ingredients and might very rarely cause a similar or identical type of clotting disorder.)
On a summer afternoon nearly four years ago, Maryam Muhammet thought her family’s long journey to freedom was almost complete. The Uyghur woman had arrived in Istanbul from Egypt weeks prior with her two sons, a toddler and an infant, after fleeing the Chinese region of Xinjiang. Her husband had not yet joined the family in Turkey. The couple had heard from others in their community that Egyptian immigration officials—ostensibly acting at the behest of the Chinese government—were hassling Uyghur men as they left, so they decided he would come later, on his own.
That afternoon, he sent Muhammet a WhatsApp message to say he was en route to the port and would travel by ship to Turkey. Soon, they would be together. But the tone of his updates quickly changed. He had encountered problems, and officials were taking him away. He loved her, he wrote. His last message came through at 6:06 p.m. “I will not lose faith in God,” he texted. He never made it to Istanbul.